-
Mashup Score: 1
A new study from the Avon Longitudinal Study of Parents and Children (ALSPAC) is challenging long-held assumptions about how we measure overweight and obesity in children. According to findings published in Obesity and Endocrinology in January 2025, body mass index (BMI) — the most commonly used tool for assessing weight status — may dramatically overestimate…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1AMA Passes Resolution Calling for Expanded Access to Anti-obesity Medications - Endocrine News - 3 day(s) ago
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Yesterday, American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. https://t.co/rBdTh5dTiX
-
-
Mashup Score: 1AMA Passes Resolution Calling for Expanded Access to Anti-obesity Medications - Endocrine News - 4 day(s) ago
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Yesterday, American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. https://t.co/rBdTh5dTiX
-
-
Mashup Score: 0Pharma Fridays - June 6, 2025 - Endocrine News - 6 day(s) ago
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist On June 2, Regeneron Pharmaceuticals, Inc., announced a strategic in-licensing agreement with Hansoh Pharmaceuticals Group Company Limited (“Hansoh”) to acquire exclusive clinical development and commercial rights outside of the…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Pharma Fridays - June 6: @Regeneron expands #obesity portfolio with in-licensing of novel dual GLP-1/GIP receptor agonist Sandoz launches interchangeable denosumab biosimilars in U.S. Avenzo Therapeutics initiates study of CDK4 selective inhibitor https://t.co/50VeOVgXnf
-
-
Mashup Score: 3
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
.@TheEndoSociety endorses Treat and Reduce Obesity Act, which would expand access to anti-obesity medications: https://t.co/gZ6uMmapO2
-
-
Mashup Score: 3
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
.@TheEndoSociety endorses Treat and Reduce Obesity Act, which would expand access to anti-obesity medications: https://t.co/gZ6uMmapO2
-
-
Mashup Score: 5Saliva Test One Step Closer to Replacing Blood Work for Adrenal Disorder Diagnosis - Endocrine News - 10 day(s) ago
Salivary cortisol and cortisone can be valuable tools in diagnosing adrenal insufficiency (AI), offering non-invasive options for screening and potentially avoiding the need for ACTH stimulation tests in some cases, states a recent study in The Journal of Clinical Endocrinology and Metabolism. Adrenal insufficiency (AI), such as in cases of Addison’s disease and Congenital Adrenal Hyperplasia,…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Salivary cortisol and cortisone can be valuable in diagnosing adrenal insufficiency, offering non-invasive options for screening and potentially avoiding the need for ACTH stimulation tests in some cases, states a recent study in @TheEndoSociety's JCEM: https://t.co/EOpa0jtuVl https://t.co/r4VNWgUkUQ
-
-
Mashup Score: 1Easy Targets: How Endocrine-Disrupting Chemicals Affect Reproductive Endocrinology - Endocrine News - 11 day(s) ago
Endocrine-disrupting chemicals have been implicated in a wide range of of poor health outcomes, including infertility and obesity. Endocrine News speaks to Almudena Veiga-Lopez, DVM, PhD, the chair of an upcoming ENDO 2025 symposium on these chemicals’ effects on reproductive organs, which are particularly vulnerable to EDCs. Endocrine-disrupting chemicals are everywhere, and there is seemingly…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Endocrine News speaks to Almudena Veiga-Lopez, DVM, PhD, the chair of an upcoming #ENDO2025 symposium on these chemicals’ effects on reproductive organs, which are particularly vulnerable to EDCs: https://t.co/4O4ktIbvPe https://t.co/ha44ctvWJc
-
-
Mashup Score: 2
As I come to the end of my term at ENDO 2025 next month in San Francisco, Calif., I can look back with great pride at what the Endocrine Society has accomplished over the past 12 months. My experience as your president also has reaffirmed my belief that belonging to a strong community is crucial…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
As his term winds down, 2024 - 2025 @TheEndoSociety President John Newell-Price, MD, PhD, FRCP, reflects on a year of accomplishments: https://t.co/M5hIFFnaoI
-
-
Mashup Score: 3Hidden Steroids in Arthritis Supplements Raise Serious Adrenal Concerns - Endocrine News - 16 day(s) ago
Before you reach for that arthritis supplement, take note: Over-the-counter supplements could contain surreptitious glucocorticoids, notes a new case series study published in The Journal of The Endocrine Society. The study describes 12 patients who developed Cushing syndrome (CS) and/or adrenal insufficiency (AI) after consuming commonly used supplements such as Artri King, Ardosons, and Ajo…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
OTC #arthritis supplements could contain surreptitious glucocorticoids, notes a new case series study published The Journal of @TheEndoSociety : https://t.co/ROXkEWtlps https://t.co/3F3d3NTlVd
-
BMI — the most commonly used tool for assessing weight status — may dramatically overestimate overweight prevalence in children when compared with a more nuanced measure: waist-to-height ratio: https://t.co/GMRGcUgwY3